HER2-targeted Antibody Drug Conjugate Shows Promise in Patients with Non-Breast-Gastric Cancers
A HER2-targeted antibody-drug conjugate, fam-trastuzumab deruxtecan-nxki (Enhertu), showed signs of clinical activity in multiple non-breast/non-gastric cancer types, according to results from a...